Pierre Potier

This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (June 2020) (Learn how and when to remove this template message)

show This article may be expanded with text translated from the corresponding article in French. (April 2012) Click [show] for important translation instructions. View a machine-translated version of the French article. Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 4,176 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary Content in this edit is translated from the existing French Wikipedia article at [[:fr:Pierre Potier]]; see its history for attribution. You should also add the template {{Translated|fr|Pierre Potier}} to the talk page. For more guidance, see Wikipedia:Translation.

Pierre Potier (22 August 1934 – 3 February 2006) was a French pharmacist as well as a chemist. He held the position of Director of the Institut de Chimie des Substances Naturelles (1974 to 2000), as well as a teaching position at the Muséum national d'histoire naturelle. He was a member of the , the Académie des sciences, the Académie des technologies and the Academia Europaea.

Biography[]

Potier attended the Faculté de pharmacie de Paris, and then the Institut de Chimie des Substances Naturelles (ICSN) in Gif-sur-Yvette. While working at this institution he collaborated with , Derek Barton and Guy Ourisson.^[1] In 1968, he lost his wife to breast cancer.^[2] This pushed him to work on cancer. For two years from July 1994, he was the director general of research and technology at the ministère français de l'Enseignement supérieur et de la Recherche. In 1998, he received the CNRS gold medal.^[3] He was president of the Fondation de la maison de la chimie. Potier was an officer of the Légion d'honneur.

Works[]

His research was orientated towards understanding and imitating natural synthesis occurring in plants so as to produce the actif compounds in drugs. In the course of his work he perfected the tubuline test, a simple biological test permitting the rapid detection of anti-tumoral drugs.

Amongst his discoveries are vinorelbine (from the Catharanthus roseus) and docetaxel (from Taxus baccata). Docetaxel commercialised under the name Taxotere has become one of the most prescribed anti-cancer drugs in the world and was the number one source of revenue for the CNRS from patents, until the expiry of its patent. All his life he wanted to prove that public research could and should co-operate with the private sector. Potier was convinced that mutual profit could result from this co-operation.

Legacy[]

The Prix Pierre Potier was created in his honour in 2006 by the Ministry of the Economy and Finance, to encourage innovation in chemical entreprises in favour of durable development. The prize is administered by the Maison de la chimie and .^[4]

Bibliography[]

• Muriel Le Roux, "Hommage à Pierre Potier, dépasser les limites du présent", Rayonnement du CNRS, no. 41, summer 2006, p. 5-27 (in French)

References[]

This article about a French chemist is a stub. You can help Wikipedia by .

• v
• t